<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <introducedDate>2015-07-30</introducedDate>
    <calendarNumbers />
    <updateDate>2017-10-27T18:10:06Z</updateDate>
    <cosponsors>
      <item>
        <firstName>MICHAEL</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <party>R</party>
        <fullName>Sen. Crapo, Mike [R-ID]</fullName>
        <state>ID</state>
        <bioguideId>C000880</bioguideId>
        <sponsorshipWithdrawnDate />
        <lastName>CRAPO</lastName>
        <middleName>D.</middleName>
        <sponsorshipDate>2015-07-30</sponsorshipDate>
        <identifiers>
          <lisID>250</lisID>
          <bioguideId>C000880</bioguideId>
          <gpoId>8289</gpoId>
        </identifiers>
      </item>
    </cosponsors>
    <notes />
    <laws />
    <latestAction>
      <actionDate>2015-07-30</actionDate>
      <text>Read twice and referred to the Committee on Finance.</text>
      <links />
    </latestAction>
    <title>Orphan Drug Fairness Act</title>
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2015-08-18T16:36:24Z</lastSummaryUpdateDate>
          <actionDate>2015-07-30</actionDate>
          <name>Introduced in Senate</name>
          <updateDate>2015-07-30T04:00:00Z</updateDate>
          <versionCode>00</versionCode>
          <actionDesc>Introduced in Senate</actionDesc>
          <text><![CDATA[<p><b>Orphan Drug Fairness Act</b></p> <p>This bill amends the Patient Protection and Affordable Care Act (PPACA) to exclude sales of any drug or biological product approved by the Food and Drug Administration solely for rare diseases or conditions (orphan drug) from the calculation of the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. </p> <p>This Act is effective as if included in PPACA. </p>]]></text>
        </item>
      </billSummaries>
    </summaries>
    <relatedBills>
      <item>
        <latestTitle>Orphan Drug Fairness Act</latestTitle>
        <type>HR</type>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <number>3618</number>
        <latestAction>
          <actionDate>2015-10-02</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
      </item>
    </relatedBills>
    <congress>114</congress>
    <version>1.0.0</version>
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <chamber>Senate</chamber>
          <activities>
            <item>
              <date>2015-07-30T19:38:18Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <type>Standing</type>
          <name>Finance Committee</name>
          <systemCode>ssfi00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <originChamber>Senate</originChamber>
    <committeeReports />
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Income tax credits</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>User charges and fees</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <actions>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
      <actionTypeCounts>
        <introducedInSenate>1</introducedInSenate>
        <referredToCommittee>1</referredToCommittee>
      </actionTypeCounts>
      <item>
        <actionDate>2015-07-30</actionDate>
        <committee>
          <systemCode>ssfi00</systemCode>
          <name>Finance Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionCode>10000</actionCode>
        <actionDate>2015-07-30</actionDate>
        <text>Introduced in Senate</text>
        <committee />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <type>IntroReferral</type>
        <links />
      </item>
    </actions>
    <sponsors>
      <item>
        <firstName>ROBERT</firstName>
        <bioguideId>M000639</bioguideId>
        <byRequestType />
        <identifiers>
          <gpoId>8239</gpoId>
          <lisID>791</lisID>
          <bioguideId>M000639</bioguideId>
        </identifiers>
        <fullName>Sen. Menendez, Robert [D-NJ]</fullName>
        <lastName>MENENDEZ</lastName>
        <party>D</party>
        <middleName />
        <state>NJ</state>
      </item>
    </sponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <billNumber>1906</billNumber>
    <recordedVotes />
    <cboCostEstimates />
    <billType>S</billType>
    <titles>
      <item>
        <title>Orphan Drug Fairness Act</title>
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <title>A bill to clarify the exclusion of orphan drug sales from the calculation of the annual fee on branded prescription pharmaceutical manufacturers and importers, and for other purposes.</title>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <title>Orphan Drug Fairness Act</title>
        <parentTitleType />
        <titleType>Display Title</titleType>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <createDate>2015-07-31T08:32:17Z</createDate>
    <amendments />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

